CD8A and carcinoma: We found that intratumoural lymphocytes expressing CD8, PD-1, FOXP3, TIM3, and LAG3, as well as PD-L1-expressing carcinoma cells, were each associated with better survival, independent from standard clinicopathologic factors (Table 3).